SWOG clinical trial number

CTSU/NRG-HN006

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

Open

Phase

Abbreviated Title

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

Participants

ALLIANCE, ECOG-ACRIN, NRG, SWOG

Research committees

Early Therapeutics & Rare Cancers

Other Clinical Trials

SWOG Clinical Trial Number

S2505

Phase III Randomized Study Testing Non-Inferiority of Short-Course Ultra-Hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) for Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma

Research Committee(s)

Early Therapeutics & Rare Cancers

Activated

07/06/2026

Open

SWOG Clinical Trial Number

SN2426

A Randomized Phase II Study of Amivantamab (JNJ-61186372) and hyaluronidase (rHuPH20) versus Cetuximab in Immunocompromised Participants with Recurrent Inoperable or Metastatic Cutaneous Squamous Cell Carcinoma

Research Committee(s)

Early Therapeutics & Rare Cancers

Sarcoma

Activated

01/28/2026

Accrual

9%

Open

Phase

SWOG Clinical Trial Number

CTSU/AOST2032

AOST2032: A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma

Research Committee(s)

Early Therapeutics & Rare Cancers

Activated

02/17/2023

Open